SHC Sotera Health Co

Nasdaq Services-Misc Health & Allied Services, NEC DE CIK: 0001822479
AI RATING
SELL
62% Confidence

Investment Thesis

Sotera Health Co faces significant financial headwinds including negative free cash flow (-$16.7M), elevated leverage (3.44x debt/equity), and weak capital returns (4.3% ROE) despite operational profitability. The company must address its unsustainable capital expenditure pattern exceeding operating cash flow while managing high debt levels, though adequate liquidity provides near-term runway.

Strengths

  • + Strong gross margins (52.5%) and solid operating margins (15.2%) demonstrate operational efficiency
  • + Steady revenue growth of 5.7% year-over-year shows market traction
  • + Robust short-term liquidity (2.82x current ratio, 2.54x quick ratio) provides financial flexibility
  • + Adequate cash reserves of $314.1M provide sufficient operational runway
  • + Profitable on GAAP basis with 9.5% net margin

Risks

  • ! Negative free cash flow of -$16.7M indicates company burning cash despite accounting profitability
  • ! Highly elevated debt/equity ratio of 3.44x creates significant financial leverage risk
  • ! Poor capital efficiency evidenced by very low ROE (4.3%) and ROA (0.8%)
  • ! Net income flat year-over-year despite revenue growth signals margin compression
  • ! Capital expenditure ($46.2M) significantly exceeds operating cash flow ($29.4M) creating unsustainable spending pattern
  • ! Interest coverage ratio unavailable raises questions about debt servicing adequacy

Key Metrics to Watch

Financial Metrics

Revenue
280.0M
Net Income
26.6M
EPS (Diluted)
$0.09
Free Cash Flow
-16.7M
Total Assets
3.2B
Cash
314.1M

Profitability Ratios

Gross Margin 52.5%
Operating Margin 15.2%
Net Margin 9.5%
ROE 4.3%
ROA 0.8%
FCF Margin -6.0%

Balance Sheet & Liquidity

Current Ratio
2.82x
Quick Ratio
2.54x
Debt/Equity
3.44x
Debt/Assets
80.8%
Interest Coverage
N/A
Long-term Debt
2.1B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-07T10:32:29.485163 | Data as of: 2026-03-31 | Powered by Claude AI